HRP20130496T1 - Pripravci koji emitiraju pozitrone i sadrže anorganske äśestice, te njihova upotreba u medicini, osobito u dijagnostiäśkim postupcima - Google Patents

Pripravci koji emitiraju pozitrone i sadrže anorganske äśestice, te njihova upotreba u medicini, osobito u dijagnostiäśkim postupcima

Info

Publication number
HRP20130496T1
HRP20130496T1 HRP20130496AT HRP20130496T HRP20130496T1 HR P20130496 T1 HRP20130496 T1 HR P20130496T1 HR P20130496A T HRP20130496A T HR P20130496AT HR P20130496 T HRP20130496 T HR P20130496T HR P20130496 T1 HRP20130496 T1 HR P20130496T1
Authority
HR
Croatia
Prior art keywords
medicine
inorganic particles
containing inorganic
diagnostic processes
emitting positrons
Prior art date
Application number
HRP20130496AT
Other languages
English (en)
Inventor
Kristian Schilling
Original Assignee
Nanopet Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanopet Pharma Gmbh filed Critical Nanopet Pharma Gmbh
Publication of HRP20130496T1 publication Critical patent/HRP20130496T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20130496AT 2007-06-22 2013-06-06 Pripravci koji emitiraju pozitrone i sadrže anorganske äśestice, te njihova upotreba u medicini, osobito u dijagnostiäśkim postupcima HRP20130496T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07110908A EP2005973A1 (de) 2007-06-22 2007-06-22 Positronen emittierende anorganische Partikel enthaltende Zusammensetzungen und deren Verwendung in der Medizin, insbesondere für diagnostische Verfahren
PCT/EP2008/057917 WO2009000785A2 (de) 2007-06-22 2008-06-20 Positronen emittierende anorganische partikel enthaltende zusammensetzungen und deren verwendung in der medizin, insbesondere für diagnostische verfahren

Publications (1)

Publication Number Publication Date
HRP20130496T1 true HRP20130496T1 (hr) 2013-08-31

Family

ID=38624000

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20130496AT HRP20130496T1 (hr) 2007-06-22 2013-06-06 Pripravci koji emitiraju pozitrone i sadrže anorganske äśestice, te njihova upotreba u medicini, osobito u dijagnostiäśkim postupcima

Country Status (13)

Country Link
US (1) US8894968B2 (hr)
EP (2) EP2005973A1 (hr)
JP (1) JP5635400B2 (hr)
CN (1) CN101801421B (hr)
CA (1) CA2691580C (hr)
DK (1) DK2160202T3 (hr)
ES (1) ES2421441T3 (hr)
HR (1) HRP20130496T1 (hr)
IL (1) IL202870A (hr)
PT (1) PT2160202E (hr)
RU (1) RU2461392C2 (hr)
SI (1) SI2160202T1 (hr)
WO (1) WO2009000785A2 (hr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2010922B1 (en) * 2006-04-03 2012-06-27 Oratel Diagnostics, LLC Methods for endometriosis screening
EP2005973A1 (de) 2007-06-22 2008-12-24 nanoPET Pharma GmbH Positronen emittierende anorganische Partikel enthaltende Zusammensetzungen und deren Verwendung in der Medizin, insbesondere für diagnostische Verfahren
KR100991716B1 (ko) * 2009-10-22 2010-11-04 경북대학교 산학협력단 광학영상 조영제, 그 용도 및 장치
WO2012024095A2 (en) 2010-08-20 2012-02-23 Oratel Diagnostics, Llc Estrous cycle monitoring by color response
US8562874B2 (en) 2011-02-28 2013-10-22 Ada Foundation Method for preparation of well-dispersed, discrete nanoparticles by spray drying techniques
US8841130B2 (en) 2011-07-11 2014-09-23 Oratel Diagnostics, Llc Methods and kit for endometriosis diagnosis
WO2018127912A1 (en) * 2017-01-03 2018-07-12 Yeda Research And Development Co. Ltd. Mri tracers comprising inorganic nanofluorides
JP6998008B2 (ja) * 2017-08-31 2022-01-18 国立研究開発法人産業技術総合研究所 分散性リン酸カルシウムナノ粒子、分散性リン酸カルシウムナノ粒子の製造方法、医薬品及び分散性リン酸カルシウムナノ粒子作製キット医薬品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
GB9020075D0 (en) * 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US5122363A (en) * 1990-12-07 1992-06-16 Board Of Regents, The University Of Texas System Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract
US7731648B2 (en) * 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
CN101080241A (zh) * 2004-12-17 2007-11-28 皇家飞利浦电子股份有限公司 用于分子成像的靶向剂
RU2007127314A (ru) * 2004-12-17 2009-01-27 Конинклейке Филипс Электроникс Н.В. (Nl) Контрастные средства или терапевтические средства направленной доставки для молекулярной визуализации и терапии
US20070264199A1 (en) * 2005-09-26 2007-11-15 Labhasetwar Vinod D Magnetic nanoparticle composition and methods for using the same
EP2005973A1 (de) 2007-06-22 2008-12-24 nanoPET Pharma GmbH Positronen emittierende anorganische Partikel enthaltende Zusammensetzungen und deren Verwendung in der Medizin, insbesondere für diagnostische Verfahren

Also Published As

Publication number Publication date
EP2005973A1 (de) 2008-12-24
US20100272637A1 (en) 2010-10-28
US8894968B2 (en) 2014-11-25
ES2421441T3 (es) 2013-09-02
RU2461392C2 (ru) 2012-09-20
DK2160202T3 (da) 2013-06-10
CN101801421B (zh) 2016-01-20
SI2160202T1 (sl) 2013-09-30
PT2160202E (pt) 2013-07-10
CA2691580A1 (en) 2008-12-31
WO2009000785A2 (de) 2008-12-31
EP2160202A2 (de) 2010-03-10
CN101801421A (zh) 2010-08-11
CA2691580C (en) 2015-11-24
EP2160202B1 (de) 2013-03-06
IL202870A (en) 2015-03-31
JP5635400B2 (ja) 2014-12-03
WO2009000785A3 (de) 2009-05-22
RU2010101926A (ru) 2011-07-27
JP2010530967A (ja) 2010-09-16

Similar Documents

Publication Publication Date Title
HRP20130496T1 (hr) Pripravci koji emitiraju pozitrone i sadrže anorganske äśestice, te njihova upotreba u medicini, osobito u dijagnostiäśkim postupcima
HK1136227A1 (en) Clay-based hemostatic agents and devices for the delivery thereof
IL216254A (en) Compounds, pharmaceutical compositions and their uses
ZA200908584B (en) Benefit agent containing delivery particle
IL206127A0 (en) Azolylmethyloxiranes, use thereof and agents containing the same
IL205360A0 (en) Methods, kits, and compositions for administering pharmaceutical compounds
IL195488A (en) Compounds, pharmaceuticals containing them and their uses
IL196167A0 (en) Bicyclic compounds and pharmaceutical compositions containing the same
ZA201000185B (en) 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
IL193340A0 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
EP2057987A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ENCAPSULATED STATINE NANOPARTICLE
IL199615A (en) Urea factories glucokinase medications containing them and their use
IL217500A0 (en) Tetrazole derivatives, their preparartion and pharmaceutical compositions containing them
HK1200446A1 (zh) 哌啶化合物、含有該化合物的藥物組合物及其用途
EP2261221A4 (en) EPOTHILONE ANALOGUES, THEIR PHARMACEUTICAL COMPOSITIONS, THEIR USE AND PREPARATIONS
IL217053A0 (en) Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
EP2208732A4 (en) DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
PT2448920E (pt) Compostos de benzeno-sulfanomidas, os seus processos de síntese e as suas utilizações na medicina
HUP0700269A2 (en) Pyrimidinyl-piperazines useful as d3/d2 receptor ligands, pharmaceutical compositions containing them and their use
PL2235013T3 (pl) Podstawione związki tetrahydroimidazopirydynowe i ich zastosowanie w farmaceutykach
GB0719248D0 (en) Compounds and methods for pharmaceutical use
EP2017257A4 (en) 2-AMINOBUTANOL COMPOUND AND ITS USE FOR MEDICAL PURPOSES
HK1141991A1 (en) Pharmaceutical composition for preventing and treating cancer and health food containing the same for preventing and treating cancer
ZA201000187B (en) 17b-cyano-19-nor-androst-4-ene derivative,use thereof and medicaments containing said derivative
IL212171A (en) 1-Phenylpyrol compounds, pharmaceuticals containing them and their use